EP Patent
EP4727536A1 — Pharmaceutical oral solid dosage forms including phenobarbital and methods of making and using the same
Assigned to Genus Lifesciences Inc · Expires 2026-04-22 · 0y expired
What this patent protects
Pharmaceutical oral solid dosage forms including at least one of phenobarbital and phenobarbital salt and methods of making and using the pharmaceutical oral solid dosage forms are disclosed.
USPTO Abstract
Pharmaceutical oral solid dosage forms including at least one of phenobarbital and phenobarbital salt and methods of making and using the pharmaceutical oral solid dosage forms are disclosed.
Drugs covered by this patent
- Deltasone (prednisone) · Generic (originally Schering)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.